Close Cookie Popup
Cookie settings
By clicking “Accept All Cookies,” you agree to the use of cookies on this website. We use cookies to provide essential site functionality, personalize content and collect analytics to support continuous improvement. You may choose to accept all cookies or customize your preferences.
Cookie settings
Close Cookie Preference Manager
Cookie settings
By clicking 'Accept all cookies', you agree to storing cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts as outlined in our privacy policy.
Necessary (Always active)
Required for core website functionality. These cookies ensure the site works properly.
Save settings

JAFRAL Partners in First Clinical Trial Combining Electrochemotherapy with IL-12 Gene Therapy

GET IN TOUCH

cONTACT
OUR EXPERT

SCHEDULE A QUICK MEET
EMAIL
info@jafral.com
PHONE NUMBER
00 386 59 340 702
ADDRESS
Stegne 13A, SI-1000 Ljubljana, Slovenia
SCHEDULE A QUICK MEET
BACTERIOPHAGESHuman therapeuticsVeterinaryFood supplementsAgricultureDermatology
BIOLOGICALSPlasmid DNAMessenger RNARecombinant ProteinsOuter Membrane VesiclesLive Biotherapeutics Products
RESOURCESNewsInsightsFact SheetsFAQ
OTHER
Fill & FinishCompanyContact

JAFRAL d.o.o.

Stegne 13A, SI-1000 Ljubljana, Slovenia+386 59 340 702info@jafral.com
LEGAL

|

PRIVACY POLICY

|

COOKIE POLICY

|

© JAFRAL